Physician profile
Toby F Handler
NPI 1891758710
$8,234.28
in general payments reported to CMS, 2019-2025
48 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,383 · 2020: $522 · 2021: $715 · 2022: $1,344 · 2023: $1,625 · 2024: $1,439 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,196 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,195.73 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,039.89 | 2020-2025 | |
| Astellas Pharma US INC | $715.93 | 2019-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $680.03 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $612.11 | 2023-2025 | Orgovyx, Gemtesa |
| Amgen INC. | $434.85 | 2019-2023 | Xgeva |
| Urogen Pharma, INC. | $409.32 | 2022-2025 | Jelmyto |
| Pfizer INC. | $398.80 | 2019-2025 | |
| Caldera Medical, INC | $395.92 | 2023 | Desara |
| Teleflex LLC | $326.91 | 2021-2025 | Urolift |
| Axonics, INC. | $281.50 | 2022-2024 | Bulkamid, Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $262.32 | 2019-2025 | |
| Myovant Sciences INC. | $238.72 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $221.46 | 2019-2023 | Xiaflex |
| Medtronic, INC. | $190.67 | 2022-2024 | Interstim |
| Ferring Pharmaceuticals INC. | $177.59 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $150.09 | 2019-2022 | |
| Procept Biorobotics Corporation | $132.68 | 2020-2025 | Aquabeam Robotic System |
| Tolmar, INC. | $128.89 | 2024-2025 | Jatenzo, Eligard, Rubraca |
| Progenics Pharmaceuticals, INC. | $124.51 | 2022-2025 | Pylarify |
| Allergan, INC. | $112.23 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $94.16 | 2019-2024 | Provenge |
| Urovant Sciences INC | $79.79 | 2021-2022 | |
| Antares Pharma, INC. | $78.05 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $71.80 | 2019-2022 | |
| Emd Serono, INC. | $70.66 | 2019-2020 | |
| Bluewind Medical | $62.38 | 2024 | Revi |
| Endo USA, INC. | $57.08 | 2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $55.82 | 2019-2022 | |
| Hollister Incorporated | $49.10 | 2021-2023 | Infyna Chic, Onli, Vapro |
| Laborie Medical Technologies Corp. | $47.88 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Clarus Therapeutics INC. | $44.26 | 2021 | |
| Ge Healthcare | $44.22 | 2019 | |
| 180 Medical, INC. | $43.12 | 2019 | |
| Palette Life Sciences, INC. | $42.77 | 2022 | |
| Boston Scientific Corporation | $42.51 | 2019 | |
| Acerus Pharmaceuticals Corporation | $39.35 | 2021-2022 | |
| Dentsply Ih INC. | $35.30 | 2019-2022 | |
| Abc Home Medical Supply, INC. | $31.31 | 2022-2024 | |
| Telix Pharmaceuticals | $27.50 | 2024 | Illuccix |
| Civco Medical Instruments | $25.03 | 2024 | |
| Myriad Genetic Laboratories, INC. | $24.29 | 2025 | Prolaris |
| Merck Sharp & Dohme LLC | $23.59 | 2023 | Lynparza, Keytruda, Welireg |
| Therapeuticsmd, INC. | $23.08 | 2019 | |
| Neotract INC. | $22.71 | 2019 | |
| Pharmaand Gmbh | $18.30 | 2025 | Rubraca |
| Avadel Specialty Pharmaceuticals, LLC | $17.77 | 2019 | |
| Mission Pharmacal Company | $14.64 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.